OJNeph  Vol.4 No.1 , March 2014
Urinary Neutrophil Gelatinase Associated Lipocalin as a Marker of Tubular Damage in Type 2 Diabetic Patients with and without Albuminuria
Abstract: Background: Neuttrophil gelatinase associated lipocalin (NGAL) was shown to be a good marker for predicting acute kidney injury (AKI). Some recent reports demonstrated that NGAL may be an early biomarker for kidney affection in diabetic patients. The aim of this work is to investigate urinary NGAL (UNGAL) in type 2 diabetic patients with and without albuminuria. Methods: This study included 46 type 2 diabetic patients and 15 healthy age and sex matched individuals as the control group. Diabetic patients were divided into three groups according to urinary albumin excretion (UAE), normoalbuminuria, microalbuminuria and macroalbuminuria. UNGAL was measured in all populations and corrected to urinary creatinine to account for day to day variation in urine volume and transformed log. Comparison between 4 groups (control, normoalbuminuria, microalbuminuria and macroalbuminuria) was done. Results: Log UNGAL/Creatinine ratio showed significant difference when comparing control group (0.70 ± 0.58) versus normoalbuminuria (1.71 ± 1.06), microalbuminuria (1.57 ± 0.72) and macroalbuminuria (1.92 ± 0.63), however, there was no significant difference among diabetic groups. Pearson’s correlation showed that log UNGAL/Creatinine ratio positively correlated with glycated hemoglobin (HbA1c) and inversely with estimated glomerular filtration rate (eGFR). Regression analysis showed that HbA1c, urinary creatinine and eGFR were the independent predictors of log UNGAL/Creatinine ratio. Conclusion: Tubular markers like UNGAL may be early elevated in type 2 diabetic patients even before the incidence of glomerular injury detected by microalbuminuria and it can be used as an early marker for detection of kidney involvement in diabetic patients.
Cite this paper: A. Al-Refai, S. Tayel, A. Ragheb, A. Dala and A. Zahran, "Urinary Neutrophil Gelatinase Associated Lipocalin as a Marker of Tubular Damage in Type 2 Diabetic Patients with and without Albuminuria," Open Journal of Nephrology, Vol. 4 No. 1, 2014, pp. 37-46. doi: 10.4236/ojneph.2014.41006.

[1]   KDOQI (2012) KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. American Journal of Kidney Diseases, 60, 850-886.

[2]   Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., McCullough, P.A., Kasiske, B.L., Kelepouris, E., Klag, M.J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D.J. and Wilson, P.W. (2003) Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PREVENTION. Hypertension, 42, 1050-1065.

[3]   American Diabetes Association (2004) Position Statement: Nephropathy in Diabetes. Diabetes Care Supplement, 27, 79-83.

[4]   Narita, T., Hosoba, M., Kakei, M. and Ito, S. (2006) Increased Urinary Excretions of Immunoglobulin G, Ceruloplasmin, and Transferrin Predict Development of Microalbuminuria in Patients with Type 2 Diabetes. Diabetes Care, 29, 142-146.

[5]   Barratt, J. and Topham, P. (2007) Urine Proteomics: The Present and Future of Measuring Urinary Protein Components in Disease. CMAJ, 177, 361-369.

[6]   Bangstad, H.J., Seljeflot, I., Berg, T.J., and Hanssen, K.F. (2009) Renal Tubulointerstitial Expansion Is Associated with Endothelial Dysfunction and Inflammation in Type 1 Diabetes. Scandinavian Journal of Clinical & Laboratory Investigation, 69, 138-144.

[7]   Thomas, M.C., Burns, W.C. and Cooper, M.E. (2005) Tubular Changes in Early Diabetic Nephropathy. Advances in Chronic Kidney Disease, 12, 177-186.

[8]   Haase, M., Bellomo, R., Devarajan, P., Schlattmann, P. and Haase-Fielitz, A. (2009) Accuracy of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute Kidney Injury: A Systematic Review and Meta-Analysis. American Journal of Kidney Diseases, 54, 1012-1024.

[9]   Peres, L.A., Cunha Júnior, A.D., Schäfer, A.J., Silva, A.L., Gaspar, A.D., Scarpari, D.F., Alves, J.B., Girelli Neto, R. and Oliveira, T.F. (2013) Biomarkers of Acute Kidney Injury. Jornal Brasileiro de Nefrologia, 35, 229-236.

[10]   Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Fazio, M.R. and Nicocia, G. (2009) Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients. Kidney and Blood Pressure Research, 32, 91-99.

[11]   Nauta, F.L., Boertien, W.E., Bakker, S.J., van Goor, H., van Oeveren, W. and de Jong, P.E. (2011) Glomerular and Tubular Damage Markers Are Elevated in Patients with Diabetes. Diabetes Care, 34, 975-981.

[12]   Tesch, G.H. and Lim, A.K. (2011) Recent Insights into Diabetic Renal Injury from the db/db Mouse Model of Type 2 Diabetic Nephropathy. American Journal of Physiology. Renal Physiology, 300, 301-310.

[13]   Stanton, R.C. (2011) Oxidative Stress and Diabetic Kidney Disease. Current Diabetes Reports, 11, 330-336.

[14]   Lim, A.K. and Tesch, G.H. (2012) Inflammation in Diabetic Nephropathy. Mediators of Inflammation, 2012, Article ID: 146154.

[15]   Paragas, N., Qiu, A., Zhang, Q., Samstein, B., Deng, S.X., Schmidt-Ott, K.M., Viltard, M., Yu, W., Forster, C.S., Gong, G., Liu, Y., Kulkarni, R., Mori, K., Kalandadze, A., Ratner, A.J., Devarajan, P., Landry, D.W., D’Agati, V., Lin, C.S. and J. Barasch, (2011) The NGAL Reporter Mouse Detects the Response of the Kidney to Injury in Real Time. Nature Medicine, 17, 216-222.

[16]   Ding, H., He, Y., Li, K., Yang, J., Li, X. and Lu, R. (2007) Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Is an Early Biomarker for Renal Tubulointerstitial Injury in IgA Nephropathy. Clinical Immunology, 123, 227-234.

[17]   Nielsen, S.E., Hansen, H.P., Jensen, B.R., Parving, H.H. and Rossing, P. (2011) Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-up Study. Nephron Clinical Practice, 118, 130-135.

[18]   Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L. and Hendriksen, S. (2006) Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate. Annals of Internal Medicine, 145, 247-254.

[19]   Burtis, E., Santos-Rosa, M., Bienvenu, J. and Whicher, J. (2006) Role of the Clinical Laboratory in Diabetes Mellitus. In: C. Bruit and E. Ashwood, Eds., Tietz Textbook of Clinical Chemistry Chapter 25, 4th Edition, Mosby, St. Louis, 837-903.

[20]   Larsen, K. (1972) Creatinine Assay by a reaCtion-Kinetic Principle. Clinica Chimica Acta, 41, 209-217.

[21]   Talke, H. and Schubert, G.E. (1965) Enzymatic Determination of Urea Using the Coupled Urease-GLDH Enzyme System. Mediators of Inflammation, 43, 174-176.

[22]   Gonen, B. and Rubenstein, A.H. (1978) Determination of Glycohemoglobin. Diabetologia, 15, 1-5.

[23]   Rowe, D.J.F., Dawnay, A. and Watts, G.F. (1990) Microalbuminuria in Diabetes Mellitus: Review and Recommendations for the Measurement of Albumin in Urine. Annals of Clinical Biochemistry, 27, 297-312.

[24]   Rodby, R.A., Rohde, R.D., Sharon, Z., Pohl, M.A., Bain, R.P. and Lewis, E.J. (1995) The Urine Protein to Creatinine Ratio as a Predictor of 24-Hour Urine Protein Excretion in Type 1 Diabetic Patients with Nephropathy. The Collaborative Study Group. American Journal of Kidney Diseases, 26, 904-909.

[25]   Brunner, H.I., Mueller, M., Rutherford, C., Passo, M.H., Witte, D. and Grom, A. (2006) Urinary Neutrophil Gelatinase-Associated Lipocalin as a Biomarker of Nephritis in Childhood-Onset Systemic Lupus Erythematosus. Arthritis & Rheumatology, 54, 2577-2584.

[26]   Gray, S.P. and Cooper, M.E. (2011) Diabetic Nephropathy in 2010: Alleviating the Burden of Diabetic Nephropathy. Nature Reviews Nephrology, 7, 71-73.

[27]   Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M.M., Ma, Q., Kelly, C., Ruff, C., S.M., Zahedi, K., Shao, M., Bean, J., Mori, K., Barasch, J. and Devarajan, P. (2005) Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker for Acute Renal Injury after Cardiac Surgery. Lancet, 8, 1231-1238.

[28]   Bolignano, D., Coppolino, G., Campo, S., Aloisi, C., Nicocia, G., Frisina, N. and Buemi, M. (2008) Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Is Associated with Severity of Renal Disease in Proteinuric Patients. Nephrology Dialysis Transplantation, 23, 414-416.

[29]   Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Campo, S., Fazio, M.R., Nicocia, G. and Buemi, M. (2009) Neutrophil Gelatinase-Associ-ated Lipocalin (NGAL) and Progression of Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology, 4, 337-344.

[30]   Alter, M.L., Kretschmer, A., Von Websky, K., Tsuprykov, O., Reichetzeder, C., Simon, A., Stasch, J.P. and Hocher, B. (2012) Early Urinary and Plasma Biomarkers for Experimental Diabetic Nephropathy. Clinical Laboratory, 58, 659-671.

[31]   Lacquaniti, A., Donato, V., Pintaudi, B., Di Vieste, G., Chirico, V., Buemi, A., Di Benedetto, A., Arena, A. and Buemi, M. (2013) “Normoalbuminuric” Diabetic Nephropathy: Tubular Damage and NGA. Acta Diabetologica, 50, 935-942.

[32]   Zachwieja, J., Soltysiak, J., Fichna, P., Lipkowska, K., Stankiewicz, W., Skowronska, B., Kroll, P. and Lewandowska-Stachowiak, M. (2010) Normal-Range Albuminuria Does Not Exclude Nephropathy in Diabetic Children. Pediatric Nephrology, 25, 1445-1451.

[33]   Kim, S.S., Song, S.H., Kim, J.J., Yang, J.Y., Lee, J.G., Kwak, I.S. and Kim, Y.K. (2012) Clinical Implication of Urinary Tubular Markers in the Early Stage of Nephropathy with Type 2 Diabetic Patients. Diabetes Research and Clinical Practice, 97, 251-257.

[34]   Nielsen, S.E., Schjoedt, K.J., Astrup, A.S., Tarnow, L., Lajer, M., Hansen, P.R., Parving, H.H. and Rossing, P. (2010) Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in Patients with Diabetic Nephropathy: A Cross-Sectional Study and the Effects of Lisinopril. Diabetic Medicine, 27, 1144-1150.

[35]   Wu, J., Ding, Y., Zhu, C., Shao, X., Xie, X., Lu, K. and Wang, R. (2013) Urinary TNF α and NGAL Are Correlated with the Progression of Nephropathy in Patients with Type 2 Diabetes. Experimental and Therapeutic Medicine, 6, 1482-1488.

[36]   Fu, W.J., Xiong, S.L., Fang, Y.G., Wen, S., Chen, M.L., Deng, R.T., Zheng, L., Wang, S.B., Pen, L.F. and Wang, Q. (2012) Urinary Tubular Biomarkers in Short-Term Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study. Endocrine, 41, 82-88.

[37]   Woo, K.S., Choi, J.L., Kim, B.R., Kim, J.E., An, W.S. and Han, J.Y. (2012) Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Comparison with Glomerular Filtration Rate for Evaluation of Renal Function in Patients with Diabetic Chronic Kidney Disease. Diabetes & Metabolism Journal, 36, 307-313.

[38]   Liebetrau, C., Dörr, O., Baumgarten, H., Gaede, L., Szardien, S., Blumenstein, J., Rolf, A., Möllmann, H., Hamm, C., Walther, T., Nef, H. and Weber, M. (2013) Neutrophil Gelatinase-Associated Lipocalin (NGAL) for the Early Detection of Cardiac Surgery Associated Acute Kidney Injury. Scandinavian Journal of Clinical & Laboratory Investigation, 73, 392-399.

[39]   Makris, K., Markou, N., Evodia, E., Dimopoulou, E., Drakopoulos, I., Ntetsika, K., Rizos, D., Baltopoulos, G. and Haliassos, A. (2009) Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) as an Early Marker of Acute Kidney Injury in Critically Ill Multiple Trauma Patients. Clinical Chemistry and Laboratory Medicine, 47, 79-82.

[40]   Wagener, G., Gubitosa, G., Wang, S., Borregaard, N., Kim, M. and Lee, H.T. (2008) Urinary Neutrophil Gelatinase-Associated Lipocalin and Acute Kidney Injury after Cardiac Surgery. American Journal of Kidney Diseases, 52, 425-433.